Table 3: Comparisons on the aspect of glucose metabolism.
Group | Time | HbA1c (%) | FPG (mmol/L) | 2hPG (mmol/L) | FINS (μIU/mL) | HOMA-IR |
Before | 7.35 ± 0.89 | 7.69 ± 1.03 | 12.02 ± 1.77 | 19.10 ± 7.36 | 6.53 ± 2.61 | |
Control | After | 6.95 ± 0.75 | 7.05 ± 0.98 | 10.95 ± 2.34 | 17.81 ± 7.89 | 5.57 ± 2.55 |
*P | 0.039 | 0.007 | 0.027 | 0.465 | 0.109 | |
Before | 7.28 ± 1.02 | 7.76 ± 0.97 | 11.81 ± 2.07 | 19.24 ± 8.82 | 6.64 ± 3.19 | |
Treated | After | 6.44 ± 0.83 | 6.50 ± 1.06 | 9.91 ± 1.99 | 16.40 ± 8.53 | 4.75 ± 2.64 |
*P | < 0.001 | < 0.001 | < 0.001 | 0.153 | 0.006 | |
#P | 0.008 | 0.025 | 0.043 | 0.464 | 0.178 |
*P value refers to comparison between before vs. after treatment within each group; #P value refers to comparison between treated and control groups after treatment; HbA1c: Glycosylated Hemoglobin; FPG: Fasting Plasma Glucose; 2hPG: 2h Post-Prandial Plasma Glucose; FINS: Fasting Insulin; HOMA-IR: Homeostatic Model Assessment for Insulin Resistance.